Cancer Research, Statistics, and Treatment

REVIEW ARTICLE
Year
: 2020  |  Volume : 3  |  Issue : 5  |  Page : 54--58

Management of hematological malignancies during the COVID-19 pandemic


Ashay Karpe1, Sunila Nagvekar-Karpe2 
1 Department of Medical Oncology, S.L. Raheja (Fortis) Hospital and HCG Hospital, Mumbai, Maharashtra, India
2 Department of Pediatrics, Mumbai and Aarya Clinic, Sterling Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Ashay Karpe
Aarya Clinic, Shop No 1, Ganjawala CHS, Near Pai Nagar Garden, Off SVP Road, Borivali (West), Mumbai - 400 092, Maharashtra
India

Coronavirus disease 2019 (COVID-19) caused by novel coronavirus, which is structurally related to the virus causing severe acute respiratory syndrome, has emerged as a global health problem. During this pandemic, treatment of oncology patients especially patients with hematological malignancies has many challenges. In the absence of definite guidelines for the management of hematological cancers, we should follow certain principles for better treatment delivery with precautions to prevent COVID-19 infection in this vulnerable population with the least compromise in patient outcome


How to cite this article:
Karpe A, Nagvekar-Karpe S. Management of hematological malignancies during the COVID-19 pandemic.Cancer Res Stat Treat 2020;3:54-58


How to cite this URL:
Karpe A, Nagvekar-Karpe S. Management of hematological malignancies during the COVID-19 pandemic. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Feb 24 ];3:54-58
Available from: https://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=5;spage=54;epage=58;aulast=Karpe;type=0